Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next Steps
- PMID: 33083939
- DOI: 10.1007/s10597-020-00726-0
Screening and Treatment of Tobacco Use Disorder in Mental Health Clinics in New York State: Current Status and Potential Next Steps
Abstract
The prevalence of smoking is higher among individuals with serious mental illnesses than the general population. Evidence-based practices exist for tobacco cessation, but little is known about mental health clinics' tobacco cessation treatment practices/protocols. Mental health clinics in New York State were surveyed about their tobacco use treatment protocols and outdoor-smoking policies. One-third of clinics were not providing individual counseling for tobacco use disorder, 39% were not prescribing nicotine replacement therapy, and nearly half reported not prescribing bupropion or varenicline. Even smaller proportions reported implementing other clinical practice guidelines, with only 25.2% providing staff training and 20.3% having a dedicated staff member for coordinating tobacco use disorder treatment. Regarding outdoor smoke-free policies, 38% of clinics reported not allowing any tobacco use anywhere on grounds. Despite some successes, many clinics do not provide evidence-based tobacco use treatments, meaning important opportunities exist for mental health clinics and oversight agencies to standardize practices.
Keywords: Clinics; Serious mental illnesses; Smoking; Tobacco.
References
-
- A Guide to the New York State Clean Indoor Air Act. (2018). New York State Department of Health. Retrieved from https://www.health.ny.gov/publications/3402/
-
- Anthenelli, R. M., Benowitz, N. L., West, R., St. Aubin, L., McRae, T., Lawrence, D., et al. (2016). Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. The Lancet, 387(10037), 2507–2520. https://doi.org/10.1016/S0140-6736(16)30272-0 . - DOI
-
- Barber, S., & Thornicroft, G. (2018). Reducing the mortality gap in people with severe mental disorders The role of lifestyle psychosocial interventions. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2018.00463 . - DOI - PubMed - PMC
-
- Breslau, J., Yu, H., Horvitz-Lennon, M., Leckman-Westin, E., Scharf, D. M., Connor, K. L., et al. (2017). Enrollment of specialty mental health clinics in a state medicaid program to promote general medical services. Psychiatric Services, 68(1), 63–69. https://doi.org/10.1176/appi.ps.201600104 . - DOI - PubMed
-
- Cerimele, J. M., Halperin, A. C., & Saxon, A. J. (2014). Tobacco use treatment in primary care patients with psychiatric illness. Journal of the American Board of Family Medicine, 27(3), 399–410. https://doi.org/10.3122/jabfm.2014.03.130252 . - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
